TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA)

Historical Holders from Q4 2019 to Q3 2025

Symbol
TELA on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
44,542,200
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
23,562,953
Holdings value
$35,108,965
% of all portfolios
0.001%
Number of holders
40
Number of buys
11
Number of sells
-16
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EW HEALTHCARE PARTNERS FUND 2, L.P. 17.32% $11,572,064 7,714,709 EW Healthcare Partners Fund 2 GP, L.P. 17 Nov 2025
Nantahala Capital Management, LLC 12.9% +29.1% $4,804,893 +$1,069,026 5,111,588 +28.6% Nantahala Capital Management, LLC 30 Apr 2025
NORTH RUN CAPITAL, LP 9.3% +86% $3,608,839 +$1,666,000 3,682,489 +85.8% North Run Capital, LP 31 Mar 2025
SILVERARC CAPITAL MANAGEMENT, LLC 7.8% $2,881,710 3,065,649 SilverArc Capital Management, LLC 31 Dec 2024
LYTTON LAURENCE W 7.2% -14.4% $4,269,304 -$832,740 2,865,305 -16.3% Lytton, Laurence W. 30 Sep 2025
Stonepine Capital Management, LLC 6% $2,211,913 2,353,099 Stonepine Capital Management, LLC 31 Dec 2024
HIRSCHMAN ORIN 3.6% -45.7% $1,331,344 -$1,171,674 1,416,323 -46.8% Orin Hirschman 31 Mar 2025

Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 23,562,953 $35,108,965 +$70,979 $1.49 40
2025 Q2 23,475,441 $45,542,765 -$775,817 $1.94 45
2025 Q1 24,589,431 $30,000,578 -$5,393,768 $1.22 47
2024 Q4 27,032,996 $81,640,185 +$27,788,571 $3.02 46
2024 Q3 18,012,190 $45,588,967 -$10,956,793 $2.53 48
2024 Q2 19,879,104 $93,430,843 -$6,702,626 $4.7 67
2024 Q1 20,686,484 $117,292,014 -$1,655,166 $5.67 58
2023 Q4 20,961,753 $138,767,513 -$8,011,684 $6.62 59
2023 Q3 21,852,278 $174,816,904 -$1,837,658 $8 66
2023 Q2 22,055,151 $223,420,734 +$51,494,354 $10.13 67
2023 Q1 16,939,491 $180,199,912 -$5,749,423 $10.64 54
2022 Q4 17,430,212 $200,446,271 +$6,246,137 $11.5 49
2022 Q3 16,786,563 $143,023,324 +$28,855,257 $8.52 43
2022 Q2 13,534,368 $95,028,004 +$13,917,248 $7.01 31
2022 Q1 11,160,859 $129,798,000 +$6,753,935 $11.63 29
2021 Q4 10,531,506 $134,807,000 -$160,970 $12.8 34
2021 Q3 10,239,091 $139,838,000 -$320,790 $13.66 35
2021 Q2 10,239,149 $164,948,850 +$6,022,396 $16.11 43
2021 Q1 9,891,266 $147,387,000 +$2,988,786 $14.9 46
2020 Q4 9,690,658 $145,766,000 -$988,972 $15.04 47
2020 Q3 9,752,756 $161,293,000 +$2,115,756 $16.54 43
2020 Q2 9,735,757 $126,197,000 +$43,684,111 $12.96 49
2020 Q1 6,476,845 $50,649,000 -$2,643,965 $7.82 26
2019 Q4 6,384,233 $82,677,000 +$79,084,000 $12.95 22